Forlenza, Gregory P.
Messer, Laurel H.
Berget, Cari
Wadwa, R. Paul
Driscoll, Kimberly A.
Article History
First Online: 26 September 2018
Compliance with Ethical Standards
:
: Cari Berget and Kimberly Driscoll declare that they have no conflict of interest.Dr. Forlenza reports research support from the NIH NIDDK, Medtronic, Tandem, Insulet, Dexcom, Abbott, Novo Nordisk, Type Zero, and Beta Bionics. Dr. Forlenza has served as an advisory board member for Dexcom, a paid consultant for Medtronic and Abbott, and a speaker for Tandem, Dexcom, and Medtronic.Mrs. Messer is a Contract Product Trainer for Medtronic Diabetes and has received speaking honoraria from Tandem Diabetes Care.Dr. Wadwa reports research support from Lexicon, Dexcom, Bigfoot Biomedical, MannKind Corporation, Novo Nordisk, Helmsley Charitable Trust and NIH/NIDDK, advisory board consulting fees from Eli Lilly and Company, and consulting fees from Dexcom.
: This article does not contain any studies with human or animal subjects performed by any of the authors.